Global stock markets jumped on Wednesday after the release of more upbeat data about the COVID-19 vaccine being developed by Pfizer and BioNTech. Traders have this month been encouraged by announcements of progress toward possible vaccines and on Wednesday
The setback for CoronaVac came on Monday as US pharmaceutical giant Pfizer said its own vaccine candidate had shown 90 per cent effectiveness — sending global markets soaring and raising hopes of an end to the pandemic.
Pfizer Inc and BioNTech announced on Monday that the result of their clinical trial for COVID-19 vaccine has proven to be more than 90% effective.
Finally, there seems to be some light at the end of what looks like a long, long tunnel. After being pummelled by the ravages of the much hated and feared coronavirus for months, which has killed over a million people,
The US Food and Drug Administration has not said how long it will take to study the vaccine data, but the government expects to give the green light for the vaccine in the first two weeks of December.
The beginning of vaccinations could be a crucial shift in the battle against a virus that has claimed more than 1.4 million lives worldwide, including 255,000 just in the US, since emerging from China late last year.
The measures are for participants in the vaccine trial immediately after their first dose and also for those in the National Vaccination Programme 28 days after their second dose.
It is the first time Pakistan has participated in such a trial, which comes amid a string of positive vaccine announcements by Western pharmaceutical companies this month.
It has the capability to store vaccines and other pharmaceutical products at a range of up to -80 degree as it is equipped with temperature and humidity systems monitored digitally via a control dashboard.